Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Immunoassay Immunochem ; 45(2): 93-111, 2024 Mar 03.
Artigo em Inglês | MEDLINE | ID: mdl-38174954

RESUMO

Hashimoto's thyroiditis (HT) and Graves' disease (GD) susceptibility depends on a complex interaction between environmental and genetic factors. Genes for tumor necrosis factor alpha (TNF-α) and toll-like receptors (TLRs) have been incorporated into the pathophysiology of autoimmune disorders. Our aim is to assess the association between TLR7 (rs179009) and TNF-α (rs1800629) polymorphisms and susceptibility to autoimmune thyroid disorders. One-hundred ninety-nine individuals, divided into 68 HT patients in group I, 57 GD patients in group II, and 74 age- and gender-matched healthy subjects in group III, underwent laboratory investigations, including the detection of TLR7 and TNF-α polymorphisms using real-time PCR technique. TLR7 (rs179009) genotypes, A/G and G/G, were significantly more prevalent in HT patients (group I) compared to normal controls. Meanwhile, TNF-α (rs1800629) genotypes in GD patients (group II) showed a six fold increase in the risk of the disease in the G/A and A/A genotypes. Our findings propose the fact that the polymorphisms of TLR7 (rs179009) play a role in the susceptibility and the development of Hashimoto's thyroiditis, whereas TNF-α (rs1800629) polymorphisms play a role in the susceptibility and development of Graves' disease.


Assuntos
Doenças Autoimunes , Doença de Graves , Doença de Hashimoto , Humanos , Egito , Predisposição Genética para Doença/genética , Doença de Graves/genética , Doença de Graves/patologia , Doença de Hashimoto/genética , Polimorfismo de Nucleotídeo Único/genética , Receptor 7 Toll-Like/genética , Fator de Necrose Tumoral alfa/genética
2.
Front Plant Sci ; 13: 897795, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36035667

RESUMO

Medicinal plants have been used to cure human diseases since decades. Silybum marianum, a medicinal plant, is regarded as a source of secondary metabolites with therapeutic value against liver diseases and diabetes. The present study was conducted to enrich the production of secondary metabolites in the vegetative parts of Silybum marianum using elicitation strategy in hydroponic system with different elicitors. The elicitors of fungus Aspergillus niger (0.2 g/L), methyl jasmonate (MeJA) (100 µM) and silver nanoparticles (AgNPs) (1 ppm) were added in hydroponic medium, individually and in combination form to the 15 days old plant. The elicitor-treated plants were harvested at different time points (24-144 h; increment 24 h) and their biochemical parameters like phenolics, flavonoids, nitric oxide (NO), and superoxide dismutase (SOD) were analyzed. The results showed hyper-accumulation of these biochemical contents, especially in response to MeJA (100 µM), followed by AgNPs (1 ppm) and co-treatment of AgNPs (1 ppm) with other elicitors. The results revealed that the treatment with MeJA (100 µM) exhibited the highest flavonoid (304 µg g-1), phenolic (372 µg g-1), and SOD (16.2 U g-1) contents. For NO levels, the maximum value of 198.6 nmole g-1 was achieved in response to the treatment with MeJA + Green synthesized AgNPs (100 µM + 1 ppm). Our findings depicted an enhanced production of medicinally important plant secondary metabolites and antioxidants; hence, the method applied in this study can play a significant role to improve therapeutic values of the plants.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...